We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Molecules Can Make Heart Muscle from Stem Cells

By Biotechdaily staff writers
Posted on 24 Feb 2004
Researchers have identified small molecules that can cause embryonic stem cells to selectively differentiate into cardiomyocytes, or heart muscle cells.

Normally, cells develop along a pathway of increasing specialization, but scientists have been seeking ways to selectively differentiate stem cells into specific cell types. More...
Researchers theorized that if stem cells were exposed to certain synthetic chemicals, they might selectively differentiate. To test this hypothesis, they screened about 100,000 small molecules from a combinatorial small molecule library they had previously synthesized.

Working with this assortment, the researchers designed a method to identify molecules able to differentiate the mouse embryonic stem cells into heart muscle cells. They engineered embryonal carcinoma (EC) cells with a reporter gene encoding a protein called luciferase, which they inserted downstream of the promoter sequence of a gene that is only expressed in cardiomyocytes. Then the EC cells were placed into separate wells and different chemicals from the library were added to each. The engineered EC cells induced to become heart muscle cells expressed luciferase, which made the well glow, distinguishing it from tens of thousands of other wells when examined with high-throughput screening equipment.

A number of molecules were able to induce the differentiation of EC cells into cardiomyocytes, and the researchers chose one called Cardiogenol C for further studies. Using Cardiogenol C, scientists reported they could selectively induce more than half of the stem cells in their tests to differentiate into cardiac muscle cells. Existing methods are reported to result in merely 5% of the stem cells becoming the desired cell type.

"It's hard to control which specific lineage the stem cells differentiate into,” said first author Xu Wu, a doctoral candidate in the Kellogg School of Science and Technology at the Scripps Research Institute (La Jolla CA, USA; www.scripps.edu). "We have discovered small molecules that can turn embryonic stem cells into heart muscle cells.” Also taking part in the study were researchers from the Genomics Institute of the Novartis Research Foundation (San Diego, CA, USA).




Related Links:
Scripps
Genomics Inst.

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.